Clinical trial Recruiting at 1 site Observational Ages 14 to 18

Understanding how metabolism and inflammation affect diabetes in teens

Official title: The Role of Circulating Meta-Inflammatory Monocytes in Adolescent Insulin Resistance

Run by University of Michigan · NCT06007404 · Data updated 2026-11-12

This study is trying to see how body weight, lifestyle, and diet affect inflammation and metabolism in teens to better understand diabetes risk.

Quick facts

Study typeObservational
Ages14 Years to 18 Years
SexAll
Enrollment175 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedSeptember 6, 2023
Main results expectedDecember 2026
Study endsSeptember 2027
Registry record updatedOctober 15, 2026
Trial IDNCT06007404 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents aged 14 to 18 who are at various weight categories or diagnosed with Type 2 Diabetes.

Probably not a fit

Patients who are currently pregnant or have conditions that affect glucose metabolism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect health-related information and blood samples from adolescents to explore the relationship between body composition, lifestyle habits, and diet on meta-inflammatory monocytes (MiMos). The researchers hypothesize that adolescents at risk for metabolic diseases exhibit increased MiMo activity, which may contribute to insulin resistance. By analyzing these factors, the study seeks to provide insights into the mechanisms underlying diabetes and related conditions in this age group.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and prevention strategies for diabetes and metabolic diseases in adolescents.

How similar studies have gone: While this approach is focused on a specific adolescent population, similar studies have shown promise in understanding metabolic diseases and inflammation in other demographics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Between 14 and 18 years of age
* Tanner stage 4 or 5 (mature adult stage of puberty)
* Normal weight (BMI ≥ 5th percentile \& \< 85th percentile), overweight (BMI \> 86th percentile) \& \< 94th percentile), obese weight (BMI percentile ≥ 95th percentile), and/or pre-diabetes (HbA1c \> 5.7%)
* For Type 2 Diabetes cohort, diagnosis of Type 2 Diabetes

Exclusion Criteria:

* Currently pregnant
* Use medications known to affect glucose metabolism (immunosuppressive medications, cancer medications, or high dose steroids), unless prescribed for Type 2 Diabetes management
* Prior diagnosis of autoimmune disease, cancer, or a cognitive or perceptual disability that would inhibit following directions of study staff
* Allergies or intolerance to milk, soy, or palm oil

Where it's running

  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.